Why Self-Medicating With Psychedelics Can Be Risky
Last reviewed and updated: May 29, 2026.
Key Takeaways
| Biggest clinical risk | No psychiatric screening โ psychedelics can destabilize undiagnosed bipolar disorder or psychotic conditions |
| Legal status (U.S.) | Psilocybin, LSD, DMT remain Schedule I in most states; Oregon and Colorado have legal psilocybin frameworks |
| Dosage problem | Unregulated substances have unknown potency; some (e.g. NBOMe compounds sold as LSD) carry serious physical risks |
| What clinical settings add | Psychiatric screening, trained support during the experience, and structured integration โ the elements that produce therapeutic results |
| Legal alternatives | Ketamine therapy (legal, 1,800+ U.S. clinics), Spravato (FDA-approved nasal spray), Oregon/Colorado psilocybin facilitators |
When it comes to self-medicating with any substance, there is risk involved. From side effects to potentially harmful reactions, having a certified medical professional to administer medication is always the best option.
Recent research into psychedelics indicates that these substances can effectively treat a range of health conditions. Some include depression, end-of-life anxiety in patients with a terminal illness, nicotine addiction, ketamine therapy for post-traumatic stress disorder (PTSD).
These are all conditions that can significantly disrupt someoneโs ability to function and their overall quality of life. It is promising that psychedelic compounds such as LSD, psilocybin, and ibogaine can often lead to rapid and long-lasting relief.
If living with any of these conditions, clinical study results may bring hope that a psychedelic experience could provide relief. Also, when having a treatment-resistant condition, such as treatment-resistant depression or PTSD โ which psilocybin, ketamine, and MDMA therapy can treat โ respectively, some may be more motivated to seek out psychedelics.
If psychedelics arenโt available as a legal medicine where you live, and youโre not part of a clinical trial involving psychedelics, you might think self-medicating with psychedelics is the only option you have left. There are many anecdotal reports from people who have treated a condition themselves by taking psychedelics. But self-medicating with psychedelics is not without its risks. There are reports from people who have suffered negative consequences through self-medication.
Psychedelics are powerful mind-altering substance. Taking them on your own terms is very different than taking them under the supervision of trained professionals.
To highlight the risks, see below for some key reasons why self-medicating with psychedelics shouldnโt be considered.
RELATED: The 10 Best Psychedelic Documentaries
A Lack Of Support During The Experience
A psychedelic experience can bring up a lot of difficult emotions. This is especially true when you are processing past trauma during the experience. Sometimes, negative emotions โ such as anxiety, fear, panic, and dread โ can become quite intense. Likewise, perceptual changes, hallucinations, and a loss of your sense of self or time can also be scary.
When an experience becomes overwhelming in a negative sense, it is known as a โbad tripโ. The whole experience might not be negative but a large chunk of it could be. Either way, this kind of experience may not just be frightening at the time; for many individuals, it can lead to long-term side effects, including anxiety, depression, and dissociation.
It is true that many individuals have been successful in dealing with challenging psychedelic experiences. For others, it can be hard to stay calm and grounded without support from someone else.
While taking a psychedelic in the presence of a sober โtrip sitterโ may be helpful, such a person is usually a tripperโs close friend or partner. The sitter may be experienced with psychedelics themselves. However, a trip sitter isnโt the same as taking psychedelics under the guidance of a mental health professional. A trained guide or therapist will be able to offer the kind of emotional support one needs if the experience becomes challenging. They will help navigate periods of difficulty, helping to improve the overall quality and outcome of the experience.
A Lack Of Support After The Experience
One of the most vital factors in sustaining the benefits of a psychedelic experience is integration. This refers to the process of making sense of your psychedelic experience, trying to apply the lessons and insights you gained from it to your everyday life.
Whether an experience felt overwhelmingly positive or negative, integration can often make all the difference. You may have had a โbad tripโ, but these difficult experiences can be highly valuable in the long-term. As long as youโre able to make sense of the material and emotions you experienced during the session, of course.
Some individuals may be able to integrate a psychedelic experience on their own, through individual practices such as introspection, meditation, reading, and writing. Others, in need of support with their integration, may seek insight from people on online forums. Joining a psychedelic integration group (where people discuss their psychedelic experiences in person) is also an option.
While these may seem helpful, theyโre often an inadequate replacement for talking to a therapist who was present during an experience. Additionally, this person can apply expertise and care in helping you process the material uncovered. Psychedelic therapy, in the way researchers have been exploring in clinical trials, involves several therapy sessions after the experience. These follow-up sessions can ensure that you get the most out of the experience. They will also allow you to process any difficult experiences that might otherwise leave you feeling confused and unsettled.
RELATED: What Are Psychedelics? We Explain The Differences From Other Drugs
Self-Medicating With Psychedelics And The Law
If youโre self-medicating with an illicit psychedelic, then you at putting yourself at risk of criminal prosecution. In many countries, psychedelics such as psilocybin, LSD, and DMT are schedule I substances. That means they carry the highest penalties for possession. Having a criminal record of drug possession could also impact your job prospects.
Another issue with taking an illicit psychedelic is that this might mean you want to self-medicate in secrecy. Both the illegal status and stigma surrounding these substances may affect the quality of your experience.
When taking a psychedelic as a licensed therapy, however, the experience is in a sanctioned environment, free from stigma. In this way, you can explore your experience with fewer worries.
Self-Medicating Psychedelics Outside Of A Regulated System
If you plan to purchase and take an illicit psychedelic, this means you are taking an unregulated substance. This means you might not know the dosage or potency of the product. This could result in an underwhelming experience (if the substance is less than the dose advertised). On the flip side, it could result in an overwhelming experience (if the substance is more than the advertised dose).
Worse yet, if you unintentionally take too much of the compound, you could put yourself at physical risk. A dose too high may leave out of control feelings. It may lead you feeling unaware of your surroundings. This is especially risky when home alone or walking near roads. Having someone around who can ensure your physical safety is critical.
Many psychedelics are unregulated in most countries, meaning you might be sold a drug other than the one you want. For example, some dealers are known to sell NBOMe compounds as LSD. These compounds, such as 25i-NBOMe, carry greater physical risks than LSD, and have been implicated in a number of deaths. These fatalities have involved poisoning from the substance itself as well as unpredictable, violent behavior that led to death.
Taking a psychedelic as a legal and regulated medicine brings relief that youโll receive the right drug and the dosage. You can also be sure that you wonโt be taking a compound that is contaminated with any other harmful substances. While testing substances with a reagent testing kit is wise, several kits are usually necessary to ensure an accurate result. In addition, you wonโt be able to test the dosage or purity of a substance using these kits. Some people would prefer to know exactly what theyโre taking.
RELATED: What Does โSet And Settingโ Mean When Using Psychedelics?
The Importance Of Set And Setting
The term โsetโ refers to the mindset one has going into an experience. This includes current mood, personality, and any underlying psychological conditions one has. โSettingโ, meanwhile, refers to the environment in which one takes the psychedelic. Both set and setting can profoundly impact an experience.
If self-medicating with psychedelics, one may take them in the context of a non-ideal set and/or setting. This could lead to an unpleasant experience, with potentially long-term ramifications.
In clinical trials, many patients with a history of bipolar disorder or psychotic disorders (e.g. schizophrenia) are screened out. Some of psychedelicsโ side effects can exacerbate the symptoms of these conditions.
So, while you may have depression you want to treat with psilocybin mushrooms, you may also have undiagnosed schizophrenic or manic symptoms. Self-medicating with psychedelics may put your mental health at risk. Itโs best to take psychedelics under the direction of a mental health professional. He or she will be able to assess whether youโre suitable or ready for a high dose psychedelic experience.
Additionally, trained psychedelic guides help control outside factors one may feel during an experience.
Self-medicating with psychedelics may seem like a last resort โ and you may have tried it before with successful results. But before considering this route, you should be aware of the risks. This is essential for harm reduction, and why the best ketamine therapy clinics near you may be helpful.
RELATED READING
- What Is Ketamine Therapy? Hereโs What The Research Says
- What Does โSet and Settingโ Mean When Using Psychedelics?
- Find a Verified Ketamine Clinic Near You
Before You Consider Self-Directed Psychedelic Use: A Risk Checklist
If you are seriously considering self-directed psychedelic use and cannot access a legal clinical pathway, harm reduction starts with an honest self-assessment. The following questions are drawn from the screening criteria used in clinical psychedelic trials. A โnoโ or โunsureโ to any of them is a reason to pause.
- Have you been evaluated for bipolar disorder, psychosis, or schizophrenia? Psychedelics can trigger or exacerbate manic and psychotic episodes in people with these conditions. Most clinical trials screen out this population entirely.
- Do you have a history of seizures, severe cardiovascular disease, or uncontrolled hypertension? Consult a physician before using any psychoactive substance that raises heart rate and blood pressure.
- Is a sober, trusted person present who knows what youโve taken and the dose? A โtrip sitterโ is not a substitute for a clinical guide, but their presence meaningfully reduces the risk of physical harm during a challenging experience.
- Have you tested the substance with a reagent kit? Multiple kits (Ehrlich, Hofmann, Simonโs) are needed for reliable identification. Reagent kits cannot verify dosage or purity โ only substance class.
- Are you in a safe, controlled environment โ no traffic, heights, bodies of water, or access to vehicles? Disorientation during a difficult experience can turn an ordinary setting dangerous.
- Are you in an emotionally stable period? Active grief, crisis, acute PTSD, or unresolved trauma can significantly increase the risk of a destabilizing experience.
- Do you have a plan for integration afterward? Without time and support to process what the experience surfaces, insights are less likely to translate into lasting change.
This checklist does not make self-directed psychedelic use safe โ it simply surfaces the questions that clinical programs use to protect patients. The safest path remains working with a licensed provider in a regulated setting.
Frequently Asked Questions
Is self-medicating with psychedelics illegal?
In most U.S. states and many countries, substances like psilocybin, LSD, and DMT remain Schedule I โ the highest penalty class for possession. A handful of U.S. cities (Denver, Oakland, Santa Cruz, Detroit, Seattle) and two states (Oregon, Colorado) have decriminalized or created regulated psilocybin frameworks. Outside those jurisdictions, possessing these substances carries criminal risk. Ketamine, by contrast, is a Schedule III substance that can be legally prescribed by a physician โ making clinical ketamine therapy a viable legal pathway for many who would otherwise consider self-medication.
What are the biggest risks of taking psychedelics without clinical supervision?
The main risks are: (1) no psychiatric screening โ you may have an undiagnosed condition that psychedelics can destabilize; (2) unknown dose and substance identity โ unregulated markets have no quality control, and adulterants like NBOMe compounds can be physically dangerous; (3) no professional support during a difficult experience โ a challenging trip without a trained guide can lead to panic, injury, or lasting psychological distress; (4) no structured integration โ the therapeutic value of psychedelics in clinical trials depends heavily on preparation and follow-up sessions that self-directed use typically lacks.
Whatโs the safer alternative to self-medicating with psychedelics?
For people dealing with treatment-resistant depression or PTSD, ketamine therapy is a legal, clinically supervised option available at over 1,800 verified clinics in the U.S. Esketamine (Spravato) is FDA-approved for treatment-resistant depression. Psilocybin therapy is now legally available through licensed facilitators in Oregon and Colorado. MDMA-assisted therapy is available through clinical trials for PTSD. Working through one of these pathways gets you the substance under safe conditions, with trained support and structured integration โ all the elements that make clinical psychedelic therapy effective.
Can psychedelics make mental health conditions worse?
Yes โ for certain people and conditions. Psychedelics are contraindicated in people with a personal or family history of schizophrenia, bipolar I disorder, or other psychotic disorders. They can trigger or worsen manic episodes and, in rare cases, precipitate a psychotic break in vulnerable individuals. For people with depression, anxiety, or PTSD without a psychotic history, clinical research generally shows benefit โ but even then, a challenging experience without proper support can cause lasting distress. This is why clinical screening exists: it exists to protect people for whom these substances are not appropriate.
